Literature DB >> 9666021

Efficient isolation of human immunodeficiency virus type 1 RNA from cervical swabs.

A M Hajjar1, P F Lewis, Y Endeshaw, J Ndinya-Achola, J K Kreiss, J Overbaugh.   

Abstract

An efficient method for the isolation of human immunodeficiency virus type 1 (HIV-1) nucleic acids from dry cervical swabs was developed. HIV-1 gag and env were detected in 96% (25 of 26) and 81% (21 of 26), respectively, of the samples tested by PCR from HIV-1-seropositive women in a Kenyan cohort study. Eighty-eight percent of the swabs (22 of 25) were positive for gag RNA, and 85% (17 of 20) were positive for env RNA. Fewer than 1,000 copies of HIV-1 gag RNA were detected in four swabs in which a competitive quantitative PCR assay was used. The method described here may be useful for both qualitative and quantitative analyses of HIV RNA in mucosal secretions as well as amplification and cloning of full-length viral genes for functional studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666021      PMCID: PMC105047     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.

Authors:  S Rasheed; Z Li; D Xu; A Kovacs
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

2.  Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.

Authors:  M Poss; H L Martin; J K Kreiss; L Granville; B Chohan; P Nyange; K Mandaliya; J Overbaugh
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

3.  Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species.

Authors:  M Piatak; K C Luk; B Williams; J D Lifson
Journal:  Biotechniques       Date:  1993-01       Impact factor: 1.993

4.  HIV-1 detection in endocervical swabs and mode of HIV-1 infection.

Authors:  B Zorr; A P Schäfer; I Dilger; K O Habermehl; M Kosh
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

5.  Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya.

Authors:  D B Clemetson; G B Moss; D M Willerford; M Hensel; W Emonyi; K K Holmes; F Plummer; J Ndinya-Achola; P L Roberts; S Hillier
Journal:  JAMA       Date:  1993-06-09       Impact factor: 56.272

6.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA.

Authors:  J Kreiss; D M Willerford; M Hensel; W Emonyi; F Plummer; J Ndinya-Achola; P L Roberts; J Hoskyn; S Hillier; N Kiviat
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

8.  Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood.

Authors:  J Overbaugh; R J Anderson; J O Ndinya-Achola; J K Kreiss
Journal:  AIDS Res Hum Retroviruses       Date:  1996-01-20       Impact factor: 2.205

9.  In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues.

Authors:  G J Nuovo; A Forde; P MacConnell; R Fahrenwald
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

10.  Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women.

Authors:  Y Hénin; L Mandelbrot; R Henrion; R Pradinaud; J P Coulaud; L Montagnier
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-01
View more
  4 in total

1.  Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes.

Authors:  Manish Sagar; Erin Kirkegaard; E Michelle Long; Connie Celum; Susan Buchbinder; Eric S Daar; Julie Overbaugh
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Novel methodology for antiretroviral quantitation in the female genital tract.

Authors:  Chantelle Bennetto-Hood; Victoria A Johnson; Jennifer R King; Craig J Hoesley; Edward P Acosta
Journal:  HIV Clin Trials       Date:  2009 May-Jun

Review 3.  Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs.

Authors:  Leila Fotooh Abadi; Fouad Damiri; Mehrukh Zehravi; Rohit Joshi; Rohan Pai; Mohammed Berrada; Ehab El Sayed Massoud; Md Habibur Rahman; Satish Rojekar; Simona Cavalu
Journal:  Polymers (Basel)       Date:  2022-07-29       Impact factor: 4.967

4.  Uptake of tenofovir and emtricitabine into non-monocytic female genital tract cells with and without hormonal contraceptives.

Authors:  Amanda Marie James; Jennifer R King; Ighovwerha Ofotokun; Anandi N Sheth; Edward P Acosta
Journal:  J Exp Pharmacol       Date:  2013-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.